Role of ethanol exposure on cocaine metabolism in rat hepatocytes

Journal of Applied Toxicology

Volumn 17, Issue 2, 1997, Pages 105-112

  Figliomeni, Maria L ^a   Abdel Rahman, Mohamed S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cocaine; Ethanol; Ethylcocaine; Hepatocytes; Metabolism

Indexed keywords

ALCOHOL; BENZOYLECGONINE; COCAINE; CYTOCHROME P450; DRUG METABOLITE; NORCOCAINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; HYDROLYSIS; LIVER CELL; LIVER MICROSOME METABOLISM; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; COCAINE; ETHANOL; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0030927646     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199703)17:2<105::AID-JAT413>3.0.CO;2-S     Document Type: Article

References (46)

1. S. L. Brody, C. M. Slovis and K. D Wrenn, Cocaine-related medical problems: consecutive series of 233 patients. Am. J. Med. 88, 325-331 (1990).
2. R. A. Lange, E. D. Flores, R G. Cigarroa and L. D Hillis, Cocaine-induced myocardial ischemia and infarction. Cardiology 7 (8), 74-79 (1990).
3. R. E. Chaisson, P. Bacchetti, D. Osmond, B. Brodie, M. A. Sande and A. R Moss, Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261 (4), 561-565 (1989)
4. L. E. Perino, G. H. Warren and J. Levins, Cocaine-induced hepatotoxicity in humans. Gastroenterology 93, 176-180 (1987).
5. I. R. Wanless, S Dore, N. Gopinath, J. Tan, R. Cameron, E. J. Heathcote, L. M. Blendis and G. Levy, Histopathology of cocaine hepatotoxicity Gastroenterology 98, 497-501 (1990)
6. G. C. Kanel, W. Cassidy, L. Shuster and T. B. Reynolds, Cocaine-induced liver cell injury: comparison of morphological features in man and in experimental models. Hepatology 11, 646-651 (1990).
7. M. L. Thompson, L. Shuster and K. Shaw, Cocaine-induced hepatic necrosis in mice - the role of cocaine metabolism. Biochem. Pharmacol. 28, 2389-2395 (1979).
8. P. Bouis and U A. Boelsterli, Modulation of cocaine metabolism in primary rat hepatocyte cultures: effects on irreversible binding and protein biosynthesis. Toxicol. Appl. Pharmacol. 104, 429-439 (1990).
9. S. Connors, D. R Rankin, A. J. Gandolfi, C. L. Krumdieck, L. J. Koep and K. Brendel, Cocaine hepatotoxicity in cultured liver slices: a species comparison. Toxicology 61, 171-183 (1990)
10. L. Roth, R D. Harbison, R. C James, T. Tobin and S. M. Roberts, Cocaine hepatotoxicity: influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis Hepatology 15 (5), 934-940 (1992).
11. U. A. Boelsterli, A. Lanzotti, C. Golding and M Oertle, Identification of cytochrome P-450 IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Drug Metab. Dispos. 20 (1), 96-101 (1992).
12. A. C Smith, R W. Freeman and R. D. Harbison, Ethanol enhancement of cocaine-induced hepatotoxicity. Biochem. Pharmacol. 30, 453-458 (1981)
13. C. S. Boyer and D. R Petersen, Potentiation of cocaine-mediated hepatotoxicity by acute and chronic ethanol. Alcohol Clin Exp. Res 14 (1), 28-31 (1990).
14. U. A. Boelsterli, S Atanasoski and C. Goldlin, Ethanol-induced enhancement of cocaine bioactivation and irreversible protein binding evidence against a role of cytochrome P-450IIE1 Alcohol Clin Exp Res. 15 (5), 779-784 (1991)
15. E J Raukman, G M Rosen and J Cavagnaro, Norcocaine nitroxide: a potential hepatotoxic metabolite of cocaine. Mol. Pharmacol 211, 458-463 (1982)
16. M. W. Kloss, G M Rosen and E J Raukman, Commentary cocaine-mediated hepatoxocity A critical review. Biochem. Pharmacol. 33, 169-173 (1984)
17. B. F. Grant and T. C. Harford, Concurrent and simultaneous use of alcohol and cocaine: results of national survey. Drug Alcohol Depend. 25, 97-104 (1990).
18. R. A. Dean, C. D. Christian, R. H. B. Sample and W. F. Bosron, Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine. FASEB J. 5, 2735-2739 (1991).
19. C. S. Boyer and D. R. Petersen, Enzymatic basis for the transesterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases. J Pharmacol. Exp. Ther. 260 (3), 939-945 (1992).
20. S. M. Roberts, R. D. Harbison and R. C. James. Inhibition by ethanol of the metabolism of cocaine to benzoylecognine and ecognine methyl ester in mouse and human tiver. Drug Metab. Dispos. 21 (3), 537-541 (1993).
21. R. A. Dean, E. T. Harper, N. Dumaual, D. A. Stoeckel and W. F. Bosron, Effects of ethanol on cocaine metabolism: formation of cocaethylene and norcocaethylene. Toxicol. Appt. Pharmacol. 117, 1-8 (1992).
22. M. Farre, R. De La Torre, M. LLorente, X. Lamas, B. Ugena, J. Segura and J. Cami, Alcohol and cocaine interactions in humans. J. Pharmacol. Exp. Ther. 266 (3), 1364-1373 (1993).
23. B S. Levine and I R. Tebbett, Cocaine pharmacokinetics in ethanol-pretreated rats. Drug Metab. Dispos. 22 (3), 498-500 (1994).
24. M. F. Lin, F. McGuire, P. S. Brown, M. A. Evans, C D. Christian, E. T. Harper and W. F. Bosron, Formation of the active metabolite ethyl cocaine from ethanol and cocaine in freshly isolated rat hepatocytes [abstract no. 229]. Pharmacologist 31, 159 (1989).
25. S. M. Roberts, L. Roth, R. D. Harbison and R. C. James, Cocaethylene hepatotoxicity in mice. Biochem. Pharmacol. 43 (9), 1989-1995 (1992).
26. W. L. Hearn, S. Rose, J. Wagner, A. Ciarleglios and D. C. Mash, Cocaethylene is more potent than cocaine at mediating lethality. Pharmacol. Biochem. Behav 39 (2), 531-533 (1991).
27. U A. Boelsterli, A. Wolf and C. Goldin, Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite, cocaethylene, in rat hepatocytes. Hepatology 18 (5), 1154-1161 (1993).
28. C. S. Lieber, Interaction of ethanol with drugs, hepatotoxic agents, carcinogens and vitamins. Alcohol Alcohol. 25, 157-176 (1990).
29. P S. Misra, A Lefevre, H. Ishii, E. Rubin and C. S. Lieber, Increase of ethanol, meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats Am J. Med 51, 346-351 (1971).
30. R M H Kater, F Toboon and F. L Iber, Increased rate of tolbutamide in alcoholic patients. JAMA 207, 363-365 (1969)
31. J F Pritchard and D W Schenck, Effects of ethanol and phenobarbital on the metabolism of propanolol by 9000 g rat liver supernatant Biochem. Pharmacol 26, 2453-2454 (1977).
32. G G Grassi and C Grassi, Ethanol-antibiotic interactions at hepatic level Int J. Clin Pharmacol Biopharm 11, 216-225 (1975).
33. O. A. Iseri, C. S. Lieber and L. S. Gottlieb, The ultrastructure of fatty liver induced by prolonged ethanol ingestion. Am J. Pathol. 48, 535-555 (1996).
34. E. Rubin and C S. Lieber, Hepatic microsomal enzymes in man and rats; induction and inhibition by ethanol. Science 162, 690-691 (1968).
35. E. Rubin, H. Gamg, P. Misra and C. S. Lieber, Inhibition of drug metabolism by acute ethanol intoxication. A hepatic microsomal mechanism. Am. J. Med. 49, 801-806 (1970)
36. C. Sato, M. Nakano and C. S Lieber, Prevention of acetominophen-induced hepatotoxicity by acute ethanol administration in the rat: comparison with carbon tetrachloride-induced hepatotoxicity. J. Pharmacol. Exp. Ther. 218 (3), 805-809 (1981).
37. J. M. Tredger, H. M. Smith, R. B. Read, B. Portmann and R. Williams, Effects of ethanol ingestion on the hepatotoxicity and metabolism of paracetamol in mice Toxicology 36, 341-352 (1985).
38. C. Sato and C. S. Lieber, Mechanism of the preventive effect of ethanol on acetominophen-induced hepatotoxicity J. Pharm. Exp. Ther. 218, 811-815 (1981).
39. K. E. Thummel, J. T. Slattery and S. D. Nelson, Mechanism by which ethanol diminishes the hepatotoxicity of acetominophen. J. Pharmacol. Exp. Ther. 245 (1), 129-137 (1988).
40. L. A. Reinke, F. C. Kauffman, S. A. Belinsky and R. G. Thurman, Interactions between ethanol metabolism and mixed-function oxidation in perfused rat liver: inhibition and p-nitroanisole O-demethylation, J. Pharmacol. Exp. Thee. 213, 70-78 (1980).
41. L A. Reinke, S. A. Belinsky, F. C. Kauffman, R. K Evans and R. G. Thurman, Regulation of NADPH-dependent mixed-function oxidation in perfused livers. Biochem. Pharmacol. 31 (8), 1621-1628 (1982).
42. J. Liu, C. Sato, H. Miyakawa, T. Kamiyama, K. Tajiri, M. Goto and F. Marumo. Inhibition of acetominophen hepatotoxicity by acetaldehyde in the rat. Toxicol. Lett. 62, 287-292 (1992)
43. M. N. Berry and D. S. Friend, High-yield preparation of isolated rat liver parenchymal cells J. Cell. Biol. 43, 506-520 (1969).
44. S. A. Barat, S A. Kardos and M. S. Abdel-Rahman, Development and validation of a high-performance liquid chromatography method for the determination of cocaine, its metabolites and lidocaine. J. Appl. Toxicol. 16 (3), 215-219 (1996).
45. C. S. Lieber. Biochemical factors in alcoholic liver disease. Semin. Liv. Dis. 13 (2), 136-153 (1993).
46. U. A. Boelsterli, A. Lanzotti, C. Goldlin and M Oertle, Identification of cytochrome P-450 IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Metab. Dispos. 20 (1), 96-101 (1992).